Skip to playerSkip to main content
  • 5 minutes ago
In an interview with India Today, Dr. Vishal Rao, an oncologist at HCG Cancer Centre in Bengaluru, expressed deep concern over the fake cancer drug racket uncovered in hospitals. He described the supply of counterfeit oncology medicines as a critical disaster, warning that administering ineffective treatments delays care and allows life-threatening tumours to spread. Calling the issue a systemic failure across the supply chain, Dr. Rao stated, "No, I think this is a complete disaster." He emphasised that every chemotherapy dose is essential to saving lives and moving patients toward a cure. Dr. Rao urged regulatory authorities to implement strict electronic tracking systems, such as mandatory QR codes and barcode trails from manufacturer to hospital, to verify drug authenticity. He also called for severe penalties and comprehensive investigations to dismantle the underlying nexus.

Category

🗞
News
Transcript
00:00Joining me on this broadcast is Dr. Vishal Rao, an oncologist at the HCG Cancer Centre based in Bengaluru.
00:07So you can imagine really how doctors too in the city are feeling about what's happening.
00:11Seeing these details, Dr. Rao, emerge now of a racket in which so many of these hospitals were supplied with
00:17fake drugs.
00:18As an oncologist, as someone who treats these cancer patients, your first reaction?
00:25Namaste. I think what has come to light is something very alarming, very disturbing, and I'm sure this must be
00:35something that should be immediately curbed and something where strict enforcement should take precedence.
00:44I personally feel this is something which is such a deep-rooted racket which needs to be, we need to
00:53go to the depth of this investigation because from the manufacturer to the distributor to the retailer or a hospital,
01:01I think somewhere a complete chain of trust has been broken, a chain of regulatory structure has been broken, and
01:13even a complete chain of structured protocols have been broken.
01:18How could some, from the manufacturing unit to logistics, to distributors, how is it that it's possible that the batches
01:31and the vials completely change and fake drugs enter the market?
01:34Which means that a hospital where I'm working in, if I'm giving the drug to a patient, I myself as
01:42a doctor do not know if it's real or not.
01:44Now, that's a very, very sad situation for a doctor, for a patient, and for a hospital.
01:49So, somewhere I think this is the kind of a situation wherein the regulator needs to step up, create a
01:57proper electronic tool system like barcoding or QR codes which ensure that it has got a trail, an electronic trail
02:07for authenticity to ensure that even as end users, we are feeling safe as doctors and patients.
02:14I think it's, you know, it's shocking, honestly, gives you such a sense of fear that even hospitals are not
02:21safe from these kind of rackets.
02:23But I want to understand from you, Dr. Rao, how dangerous are these fake cancer drugs for patients?
02:30What kind of harm are we talking about? Is it just a question of being ineffective? Is it a lot
02:35more serious than that?
02:40No, I think this is a complete disaster. I personally would believe that if you're giving fake drugs, and I'm
02:47saying you're talking about critical illness drugs, ICU drugs, drugs that are related to cancer.
02:53Now, these, every single door in our books, for us, each of them is life-saving. Every single door actually
03:05is able to move the patient to a cure, and if it is fake, it's as good as a placebo.
03:13That means the cancer has a chance to spread, and even threaten a person's life.
03:19So, the accountability question comes very significantly over here, because this patient somewhere who is working, who is receiving this
03:30kind of drugs.
03:31Now, typically, if you say in solid tumour, that is like lung cancer, bone cancer, headache cancer, other cancers, we
03:39give chemotherapy in very advanced stages, and in leukemias and others, they are the mainstream of treatments.
03:46Imagine, imagine in any stage of cancer, if the drug is not effective, that means it's like the next dose
03:54of therapy we give after three to four weeks, we have delayed the treatment by a month, and in one
04:00month, it's good enough for the tumour to double spread or become incurable also.
04:04And I think that onus now needs to be taken by somebody, if the patient has received it, and that
04:13pushes the patient more towards the chances of no cure or towards chances of complication.
04:19And hence, it's very, very important that we do not take this matter lightly.
04:24No, you're right, that, you know, I hope they get to the root of whatever the scam is, whoever is
04:30involved, because the suspicion is that this is a massive network.
04:32But also, Dr. Rao, you know, how you've highlighted what this means for a cancer patient, who's, you know, fighting
04:40against time, essentially to ensure that they get better by more time.
04:44And these are extremely, extremely expensive medicines.
04:48Some of them spend everything they've earned through their lives to get these dosages, to get these medications.
04:56And in Akshida, in today's unfortunate era of capital medicine, today it's not easy.
05:02People really spend heavy on insurances, heavy out-of-pocket expenditures, and even governments are spending very high amounts in
05:12their schemes in order to procure these drugs
05:14and ensure that we are able to move an inch towards cure, to giving somebody a five-year life survival,
05:21or sometimes lesser.
05:24Every day matters in their lives.
05:26And in this kind of a situation, we need to take this into the much larger picture.
05:31That if this is the story of Bengaluru, then I'm not sure what's the story in other states where vigilance
05:38and monitoring are still more worse.
05:40What could be the scale of fraud, what could be the scale of such kind of fake activities, and who
05:47all could be involved in this?
05:48So this is something that should be really investigated at the highest level, and the punishment for such kind of
05:54activity should be detrimental.
05:57No, but I have to ask this as well, Dr. Rao.
06:00You know, when we speak of accountability and the checks and balances in place right now in the country,
06:06how feasible is it for hospitals to step in here to verify the authenticity and quality of every drug that
06:12they procure,
06:13particularly these high-cost, life-saving medicines?
06:19So I think one learning lesson from this incident is a distributor who has been now held responsible for this
06:28particular thing has supplied it to the hospital.
06:31It's very important here that distributors' validation, that means every hospital knows their distributor's reputation,
06:39licenses, licenses, regularly reviews it, and governments also ensure high time that QR codes or barcoding is done from the
06:50point of manufacturing to the point of retailer
06:53to ensure that at the point of hospitals with a simple QR code, I can check if it's fake or
06:59not.
06:59Today, in the era of AI, today, there are so many easy software available that can just quickly scan and
07:07tell if something is authentic or not in other areas of consumer products.
07:13So why not in such an important area that we implemented?
07:17And I think that's the need of the hour that I see, one.
07:20Second, I would also add to say that it cannot just be a distributor in this.
07:26It has to be a complete nexus.
07:29It cannot be done by one single distributor.
07:31No, 100%.
07:32My understanding, this could be because you have to change the badges, you have to take those medicines out, then
07:37you have to fill in new medicines.
07:39That must be a complete, I would say, a complete mafia of a nexus that is very well-structured ecosystem,
07:49that is doing this regularly.
07:51You know, you're right.
07:52I don't think this is a Bengaluru problem.
07:54It's been busted in Bengaluru, but unfortunately, this could happen across and could be happening really across the country.
08:01But I have to also ask, Dr. Rao, is this an India problem, that there's a lack of regulation, there
08:07are these loopholes, that these kind of scammers, racketeers are able to go ahead and exploit?
08:12Would you ever see anything like this anywhere else in any other country?
08:19My take on this is, today, if you see that the Western countries have learned and become so tight in
08:27regulatory because they see the possibility of all of these and preempt it.
08:33Whereas, sometimes in our country, we have the best laws, but our implementation is very poor.
08:41So, what happens to us is we end up reacting every time a situation blows up and it comes to
08:46the notice, and this has happened earlier also.
08:49So, I think we need to now look at understanding and preempting such kind of situations where it's not a
08:56loophole, it's a manhole.
08:57There's clear evidence that this kind of thing, when there is such loose chains of logistics, transportation, shifting, unreliable distributors,
09:08loose distributors, unregistered distributors, is a possibility of so many leakages here.
09:15In such a situation, the regulator needs to take more stringent coherence and more stringent cognizance to ensure that there
09:24is a tight-locked system like they do for narcotic drugs.
09:29So, I think it's a good eye-opener for us to, for the regulator to ensure that this doesn't happen
09:34at all.
09:36That's right. Dr. Rao, thank you for joining us.
Comments

Recommended